Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins

We present an unusual tumorous variety of scleromyxedema mimicking facies leonina in lymphoma. In spite of pronounced and widespread cutaneous changes, hypergammaglobulinaemia and paraproteinaemia, the general condition of the patient was satisfactory, there was no internal involvement and no symptoms of any malignancy. Initially, melphalan and corticosteroids were applied but were not effective. High‐dose intravenous immunoglobulin (IVIG) therapy had dramatic effect, and after five 5‐day monthly courses the tumours almost regressed and the skin became less hard. After a further five courses in the following year there was complete clearance, which was sustained without any therapy for 1 year (until now). IVIG appears to be the therapy of choice for scleromyxedema. We stress, however, that at the start of therapy, IVIG applications should be supplemented with small doses of melphalan and/or corticosteroids.

[1]  A. Doria,et al.  Intravenous immunoglobulins control scleromyxoedema , 2002, Annals of the rheumatic diseases.

[2]  A. Bridges,et al.  Intravenous immune globulin: fighting antibodies with antibodies. , 2001, Journal of the American Academy of Dermatology.

[3]  B. Loggini,et al.  Lichen myxedematosus with systemic involvement: clinical and autopsy findings. , 2001, Journal of the American Academy of Dermatology.

[4]  T. Luger,et al.  High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin. , 2001, Journal of the American Academy of Dermatology.

[5]  A. Rebora,et al.  Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. , 2001, Journal of the American Academy of Dermatology.

[6]  P. Souteyrand,et al.  [Cutaneo-systemic papulosclerotic mucinosis (scleromyxedema): remission after extracorporeal photochemotherapy and corticoid bolus]. , 2001, Annales de dermatologie et de venereologie.

[7]  I. Forgacs,et al.  Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg). , 2000, Journal of the American Academy of Dermatology.

[8]  E. Bisaccia,et al.  Scleromyxedema with dermato-neuro syndrome. , 2000, Journal of the American Academy of Dermatology.

[9]  S. Jablonska,et al.  Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis. , 1999, European journal of dermatology : EJD.

[10]  J. Tschen,et al.  Scleromyxedema: treatment with interferon alfa. , 1999, Journal of the American Academy of Dermatology.

[11]  P. Altmeyer,et al.  Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin. , 1998, Journal of the American Academy of Dermatology.

[12]  M. Seishima,et al.  Papular mucinosis associated with scleroderma. , 1998, European journal of dermatology : EJD.

[13]  B. Guillot,et al.  Papular mucinosis with rapid spontaneous regression in an HIV-infected patient. , 1998, European journal of dermatology : EJD.

[14]  A. Pandya,et al.  Fatal scleromyxedema: report of a case and review of the literature. , 1998, Journal of the American Academy of Dermatology.

[15]  M. Boffa,et al.  Spontaneous improvement of scleromyxoedema , 1995, Clinical and experimental dermatology.

[16]  L. Matsuoka,et al.  The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis). , 1993, Journal of the American Academy of Dermatology.

[17]  D. Leung,et al.  The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases. , 1992, Clinical reviews in allergy.

[18]  D. Lookingbill,et al.  Plasmapheresis in a patient with scleromyxedema. , 1987, Archives of dermatology.

[19]  N. Ratliff,et al.  Scleromyxedema associated with scleroderma renal disease and acute psychosis. , 1986, Journal of the American Academy of Dermatology.

[20]  堀尾 武 Scleromyxedema. , 1969, Archives of dermatology.

[21]  H. Gottron Skleromyxdem: Eine eigenartige Erscheinungsform von Myxothesaurodermie , 1954 .

[22]  H. Montgomery,et al.  Lichen myxedematosus; differentiation from cutaneous myxedemas or mucoid states. , 1953, The Journal of investigative dermatology.